These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Eyelashes depigmentation following treatment with pazopanib for metastatic renal cell carcinoma. Vaccaro M; Riso G; Altavilla D; Cannavò SP Dermatol Ther; 2019 Nov; 32(6):e13140. PubMed ID: 31664777 [No Abstract] [Full Text] [Related]
3. Reversible hair depigmentation in a Japanese female treated with pazopanib. Kobayashi E; Koyama T; Kobayashi K; Setsu N; Kawashima M; Kawai A J Dermatol; 2014 Nov; 41(11):1021-2. PubMed ID: 25346306 [No Abstract] [Full Text] [Related]
4. Rapid hair depigmentation in patient treated with pazopanib. Šeparović R; Pavlović M; Silovski T; Tečić Vuger A BMJ Case Rep; 2018 Aug; 2018():. PubMed ID: 30139781 [TBL] [Abstract][Full Text] [Related]
5. An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinoma. Sternberg CN; Davis ID; Deen KC; Sigal E; Hawkins RE Oncology; 2014; 87(6):342-50. PubMed ID: 25227656 [TBL] [Abstract][Full Text] [Related]
6. Risk of Distinctive Hair Changes Associated With Pazopanib in Patients With Renal Cell Carcinoma (RCC) Versus Patients Without RCC: A Comparative Systematic Review and Meta-analysis. Elhalawani H; Heiba M; Abdel-Rahman O Clin Genitourin Cancer; 2017 Jun; 15(3):e325-e335. PubMed ID: 28189432 [TBL] [Abstract][Full Text] [Related]
9. Hair depigmentation during chemotherapy with a class III/V receptor tyrosine kinase inhibitor. Routhouska S; Gilliam AC; Mirmirani P Arch Dermatol; 2006 Nov; 142(11):1477-9. PubMed ID: 17116839 [TBL] [Abstract][Full Text] [Related]
10. Hair graying and loss induced by imatinib mesylate. Yun SK; Song KH; Hwang SR; Kim HU; Lee NR; Park J J Dermatol; 2014 Jan; 41(1):107-8. PubMed ID: 24354806 [No Abstract] [Full Text] [Related]
11. A rare case: Hallucination associated with pazopanib. Demirci NS; Erdem GU; Dogan M; Ozdemir NY; Zengin N J Cancer Res Ther; 2015; 11(4):961-2. PubMed ID: 26881556 [TBL] [Abstract][Full Text] [Related]
12. Reversible hair depigmentation in a patient treated with imatinib. Mariani S; Abruzzese E; Basciani S; Fiore D; Persichetti A; Watanabe M; Spera G; Gnessi L Leuk Res; 2011 Jun; 35(6):e64-6. PubMed ID: 21176848 [No Abstract] [Full Text] [Related]
13. Pazopanib for the treatment of metastatic renal cell carcinoma. Pick AM; Nystrom KK Clin Ther; 2012 Mar; 34(3):511-20. PubMed ID: 22341567 [TBL] [Abstract][Full Text] [Related]